| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.08 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.08 |